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Abstract
Data allowing for a complete environmental risk assessment of pharmaceuticals and their photoderatives in
the environment are still scarce. In the present study, in vitro toxicity and both bio- and photopersistence of
various pharmaceuticals (aciclovir, allopurinol, cetirizine, cimetidine, fluconazole, hydrochlorothiazide,
lisinopril, phenytoin, primidone, ranitidine, sotalol, sulpiride, tramadol and valsartane) as well as their
phototransformation products were evaluated in order to fill data gaps and to help prioritise them for further
testing. Twelve out of the fourteen compounds investigated were found to be neither readily nor inherently
biodegradable in the Organisation of Economic Cooperation and Development-biodegradability tests. The
study further demonstrates that the photo-induced transformation of the pharmaceuticals was faster upon
irradiation with a Hg lamp (UV light) than with a Xe lamp emitting a spectrum that mimics sunlight.
Comparing the non-irradiated with the respective irradiated solutions, a higher acute and chronic toxicity
against bacteria was found for the irradiated solutions of seven compounds (cetirizine, cimetidine,
hydrochlorothiazide, ranitidine, sulpiride, tramadol and valsartane). No cyto- and genotoxic effects were
found in human cervical (HeLa) and liver (Hep-G2) cells for any of the investigated compounds or their
phototransformation products. This comparative study documents that phototransformation products can
arise as a result of UV treatment of wastewater containing these pharmaceuticals. It further demonstrates that
some phototransformation products may have a higher environmental risk potential than the respective
parent compounds because some phototransformation products exhibited a higher bacterial toxicity.
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Environmental context. Many pharmaceuticals on the market have not undergone detailed evaluation for
potential aquatic toxicity.We found that most tested pharmaceuticals were persistent, that phototransformation
products were likely to be formed as a result of UV treatment of wastewater and that some transformation
products were more toxic to bacteria than their precursor pharmaceutical compound. Thus UV treatment of
wastewater does not seem appropriate to completely degrade or transform micropollutants into harmless
compounds.
Abstract. Data allowing for a complete environmental risk assessment of pharmaceuticals and their photoderatives in
the environment are still scarce. In the present study, in vitro toxicity and both bio- and photopersistence of various
pharmaceuticals (aciclovir, allopurinol, cetirizine, cimetidine, fluconazole, hydrochlorothiazide, lisinopril, phenytoin,
primidone, ranitidine, sotalol, sulpiride, tramadol and valsartane) as well as their phototransformation products were
evaluated in order to fill data gaps and to help prioritise them for further testing. Twelve out of the fourteen compounds
investigated were found to be neither readily nor inherently biodegradable in the Organisation of Economic Cooperation
and Development-biodegradability tests. The study further demonstrates that the photo-induced transformation of the
pharmaceuticals was faster upon irradiation with a Hg lamp (UV light) than with a Xe lamp emitting a spectrum that
mimics sunlight. Comparing the non-irradiated with the respective irradiated solutions, a higher acute and chronic toxicity
against bacteria was found for the irradiated solutions of seven compounds (cetirizine, cimetidine, hydrochlorothiazide,
ranitidine, sulpiride, tramadol and valsartane). No cyto- and genotoxic effects were found in human cervical (HeLa) and
liver (Hep-G2) cells for any of the investigated compounds or their phototransformation products. This comparative study
documents that phototransformation products can arise as a result of UV treatment of wastewater containing these
pharmaceuticals. It further demonstrates that some phototransformation products may have a higher environmental risk
potential than the respective parent compounds because some phototransformation products exhibited a higher bacterial
toxicity.
Additional keywords: biodegradation, HeLa cells, Hep-G2 cells, irradiation, predicted environmental concentrations
(PECs), UV, Vibrio fischeri.
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Introduction
The increasing contamination of freshwater systems worldwide
with micropollutants is a key environmental problem. Over the
last decades, pharmaceuticals have become the focus of atten-
tion.[1] Numerous studies report the presence and ecotoxicity of
pharmaceuticals in various environments, including influents
and effluents of sewage treatment plants (STPs), surface waters,
groundwater and drinking water.[2] Some pharmaceuticals are
even considered to be ubiquitous.[3] However, data allowing for
a complete environmental risk assessment are still rare espe-
cially in regard to long-term toxicity or additive and synergistic
effects.[4]
Furthermore, it is generally accepted that the persistence, fate
and effects of pharmaceuticals can only be characterised if
underlying data also relate to degradation properties of these
compounds. Biodegradation products can be formed through a
variety of natural processes, including bacterial activity in
sewage treatment plants.[5,6] Once discharged into surface
waters, products of incomplete degradation can also be formed
as a consequence of abiotic processes, such as photochemical
and photolytic processes triggered by sunlight, and hydrolysis.
All of these degradation processes can form transformation
products (TPs), which may persist in the environment and for
which neither environmental concentration nor ecotoxicity or
human toxicity are known. A few studies have already docu-
mented the existence of such TPs or have shown that a great
number of different phototransformation products (PTPs) can be
formed from a single pharmaceutical compound.[7–10] However,
these studies only focus on the structural characterisation of
PTPs and do not report any toxicity data. Because pharmaceu-
ticals and other chemical compounds are frequently detected in
surface, ground and drinking water, new technical approaches
have been tested or used to improve the quality of treated and
purified sewage water, including advanced oxidation treatment
processes (AOP), such as, ozonolysis, photolysis, chlorination,
different filtration processes and UV irradiation.[11,12] Some of
these processes have proven highly efficient in removing certain
compounds, whereas other micropollutants have been shown to
degrade only partially.[8,9,13,14] Thus, TPs are not only formed
by natural processes (e.g. sunlight), but also by water treatment.
As neither chemical properties nor environmental fate or toxici-
ty are known, any naturally or technically formed persistent TPs
are of special environmental concern. Before new technical
approaches can be widely recommended as novel water-clean-
ing technology, the effects of TPs formed as a result of this
technology on aquatic life and human beings need to be
investigated.
In order to identify environmentally relevant pharmaceuti-
cals and to evaluate their fate and effect on the aquatic
environment, we investigated the bio- and photodegradability
of 14 pharmaceutical compounds. For this purpose, three
widely used Organisation of Economic Cooperation andDevel-
opment (OECD)-standardised biodegradation tests were per-
formed as well as photodegradation tests using a Xe or Hg lamp
to respectively simulate natural sunlight and photochemical
reactions within technical processes. Further information on the
environmental risk was obtained by calculating predicted
environmental concentrations (PECs) of the compounds in
accordance with the European Medicines Evaluation Agency
(EMA) guideline.[15] All photodegradation tests were moni-
tored with regard to formation of PTPs. As a first screening
assay, and to prioritise pharmaceuticals for further conven-
tional testing, a variety of eco- and human toxicity tests were
performed with the pharmaceutical parent compounds as well
as with their PTPs.
Materials and methods
Chemicals
All chemicals used for this study were at least of analytical
grade. The active compounds were purchased from Sigma
Aldrich (Steinheim, Germany) except for aciclovir and valsar-
tane, which were respectively purchased from Dr Ehrenstorfer
(Augsburg, Germany) and USA Pharmacopeia (Rockville, MD,
USA).
All solutions were prepared using ultra-pure water, obtained
from a Milli-Q Millipore Reagent-Water-System (Eschborn,
Germany).
Environmental relevance and PECs
In order to select environmentally relevant compounds, a variety
of pharmaceutical compounds were first analysed with regard
to their PECs. Compounds were selected for this experimental
study only if their PECs exceeded the action limit of 0.01 mgL1
set by the EMA.[15]
PECs were determined in accordance with the specifications
of phase-I of the ‘Guideline on the environmental risk assess-
ment of medicinal products for human use’ recommended by
the EMA and as described elsewhere.[15,16] Briefly, the PEC
(phase-I) is based on the maximum daily dose consumed per
inhabitant (data from Germany used in this study), which is
meant to be a representation of the daily and actual consumption
rate in a worst-case scenario. Furthermore, a factor for market
penetration is used as another first and simple approach to
represent the proportion of inhabitants being treated daily with
the specific active compound. The PEC is finally calculated by
dividing these combined values through daily per-capita waste-
water flow and by considering further dilution in surface waters.
If the calculated PEC (phase-I) exceeds the action limit of
0.01 mg L1, the EMA recommends another, more precise PEC
calculation to be conducted in accordance with the specifica-
tions of phase-II of the guideline on the environmental risk
assessment.[15] Only two minor variations were made: first, the
rate of adsorption to sewage sludge was derived from the
adsorption measured in Zahn–Wellens test (see below) and
second, the consumption rate was based on updated daily
defined dose (DDD) values derived from the report released
by Schwabe and Paffrath.[17]
Briefly, the PEC (phase-II) is based on a precise calculation
of the consumption rate, which is based on DDD and its
conversion into a quantity scale by the World Health Organiza-
tion (WHO) conversion factor. To obtain a more precise PEC,
this study also considered a possible loss of the active com-
pounds through humanmetabolism by incorporating pharmaco-
kinetic data (http://www.fachinfo.de/, accessed 24 May 2014).
Biodegradation tests
To evaluate the PTPs of the studied recalcitrant pharmaceutical
compounds, as a first step, a more detailed evaluation was
performed on biological degradation. For this purpose three
different biodegradation tests were applied in accordance to the
1992 OECD test guidelines described in detail elsewhere.[16]
The standard test period for all biodegradation experiments was
28 days, and all test series were run as duplicates. Table 1
summarises all different biodegradation test vessels that were
used for the three types of biodegradation tests.
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Closed bottle test (CBT)
The CBT (OECD 301D) is recommended by the OECD
(1992) as a first test for assessing whether or not organic
compounds are readily biodegradable in the aquatic environ-
ment. Accordingly, the CBT was performed with a low bacte-
rial density, a low nutrient content, and with a low
concentration of test compound (see Table 2). The amount of
each test compound corresponded to a theoretical oxygen
demand (ThOD) of 5mgL1 (without nitrification). According
to the test guideline, a test compound is classified as readily
biodegradable if biodegradation, expressed as the percentage
of oxygen consumed in the test vessel, exceeds 60% within a
period of 10 days after oxygen consumption reached 10%.
All test vessels were inoculated with an aliquot from the
effluent of a local municipal sewage treatment plant (STP)
(STP Kenzingen, Germany; 13 000 inhabitant equivalents).
Two drops of inoculum were added to 1 L of medium. The
process of aerobic biodegradation was monitored daily by
measuring oxygen concentration in the test vessels with an
optode oxygen sensor system (Fibox 3 PreSens, Regensburg,
Germany), except for allopurinol, hydrochlorothiazide, raniti-
dine and tramadol, forwhich the oxygen concentration in the test
vessels was measured with an oxygen electrode (Oxi 196 with
EO 196-1.5, WTW Weilheim, Germany).
Manometric respirometry test (MRT)
TheMRT (OECD301F) is a second test recommended by the
OECD for assessing whether or not organic compounds are
readily biodegradable in the aquatic environment. Compared to
the CBT and the Zahn–Wellens test (see below), it was per-
formed with a medium bacterial density, a medium nutrient
content and a medium concentration of test compound (see
Table 2). The amounts of test compounds corresponded to a
ThOD of 30mgL1. In analogy to the CBT, a test compound
was classified as readily biodegradable if biodegradation,
expressed as the percentage of oxygen consumed in the test
vessel, exceeded 60% within a period of 10 days after oxygen
consumption reached 10%.
All test vessels were inoculated with 40 mL of an aliquot
from the effluent of the same STP as in the CBT. Aliquots of
80 mL were added to 1 L of mineral media. The process of
aerobic biodegradation was measured automatically and daily
by using an automatic analyser (System OxiTop OC100,
WTW, Weilheim, Germany), which determines the microbial
oxygen consumption by measuring CO2 production through
pressure measurements.
Zahn–Wellens test (ZWT)
The ZWT (OECD 302B) is a tier-2 biodegradability test
recommended by the OECD for assessing the inherent biode-
gradability of organic compounds, e.g. in sewage treatment.
For assessment of inherent biodegradability, a high nutrient
content and a high bacterial diversity are commonly used. With
concentrations of the test compounds equivalent to 50 mg of
dissolved organic carbon (DOC) per litre (77–177 mg L1),
the compounds were added to the test containers as the only
Table 1. Composition of biodegradation test series in the closed bottle test (CBT), manometric respirometry test (MRT) and Zahn–Wellens test
(ZWT)
Test series Composition
Mineral medium Inocula Test compound Reference compound Sodium azide
Blank þ þ   
Quality control þ þ  þ 
Test compound þ þ þ  
Toxicity control þ þ þ þ 
Sterile and negative control þ  þ  þ
Table 2. Test concentration and biodegradability of test compounds in the three biodegradation tests
CBT, closed bottle test;MRT,manometric respirometry test; ZWT, Zahn–Wellens test; BD, biodegradation, measured as oxygen consumption in the CBT and
MRT and as dissolved organic carbon reduction in the ZWT
Test compound CBT MRT ZWT
Concentration BD Concentration BD Concentration BD
(mg L1) (%) (mg L1) (%) (mg L1) (%)
aciclovir 7.0 0 42.1 0.2 100.5 14.0
allopurinol 8.5 0 51.0 0 113.3 0
cetirizine 3.0 1.8 18.0 2.4 93.5 0
cimetidine 3.6 3.4 21.5 4.5 105.1 10.6
fluconazol 4.6 0.8 27.3 0 109.3 0
hydrochlorothiazide 6.2 0 37.2 16.2 177.1 0.2
lisinopril 2.9 0 17.2 0 94.8 68.8
phenytoin 2.8 0 16.6 0 77.0 6.8
primidone 2.6 0 15.7 12.0 75.7 40.1
ranitidine 3.5A 0A 21.2A 0A 112.5A 0A
sotalol 3.1 2.7 17.9 3.6 109.3 71.2
sulpiride 3.0 3.0 17.8 0.8 94.8 15.0
tramadol 2.3A 0A 13.7A 0.1A 78.8A 0A
valsartane 2.6 0 15.7 0 105.1 29.8
AData from Bergheim et al.[16]
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source of carbon. A test compound is classified as inherently
biodegradable if the DOC concentration was reduced by more
than 70%.
The sludge required as inoculum was obtained from the
STP at Kenzingen (see CBT). The dry matter content in all
test vessels was adjusted to 5.0 g L1. The process of aerobic
biodegradation was monitored at specific time intervals by
measuring DOC loss in the test vessels with a total organic
carbon (TOC) analyser (TOC 5000, Shimadzu GmbH, Duis-
burg, Germany).
DOC measurement
The progress of aerobic or anaerobic biodegradation as well as
the degradation by photochemical processes or photolysis were
monitored by measuring the DOC content. The latter was
determined in three replicates according to European standard
procedure EN 1484 by using a TOC analyser (TOC 5000, Shi-
madzu GmbH, Duisburg, Germany). Prior to chemical analysis,
samples of the biodegradation test were filtered (cut-off
0.45 mm, Sartorius, Goettingen, Germany) in order to meet the
conditions for DOC measurements, and measured continually
over the course of the 28-day test period. Samples of the irra-
diation experiments were measured directly after irradiation for
fixed time periods (2, 4, 8, 16, 32, 64 and 128min).
High performance liquid chromatography–UV–mass
spectrometry (HPLC-UV-MS) analysis
A HPLC system (Agilent Technologies, Waldbronn, Germany,
HPLC 1100 series) consisting of two G1312A binary pumps, an
ALS G1329A þ ALS Therm G1330B sampler, a G1316A
column oven (temperature set at 40 8C) and a G1322A degasser
(Agilent, Germany) was used for chemical analysis. Chromato-
graphic separationwas performed on an RP-18 column (CC 70/3
NUCLEODUR 100-3 C18 ec, Macherey and Nagel, Dueren,
Germany), protected by a CC 8/4 NUCLEODUR 100-5 C18 ec
(Macherey and Nagel, Dueren, Germany) guard column. For
elution, 0.1% formic acid in water (HCOOH: solution A) and
100% acetonitrile (CH3CN: solution B) were used by applying
the following linear gradient: 0min 1% B, 20min 45% B,
22.3min 55% B, 25min 80% B, 26min 1% B, 30min 1% B.
The sample injection volumewas 20mL, and the flow ratewas set
to 0.5mLmin1. The total run timewas 30min. Test compounds
at concentrations of 1, 2.5, 5, 10, 25 and 50mgL1 were used to
establish the corresponding standard calibration curves. Quality
controls at 10mgL1 were included in each run and were within
20% bias. The protonated molecule of each compound was
monitored for quantification. Samples were either directly ana-
lysed or stored at 80 8C for subsequent analysis.
Quantification and detection were performed on a Bruker
Daltonic Esquire 6000 plus ion trap mass spectrometer (IT-MS)
equipped with a Bruker data analysis system and an atmospheric
pressure electrospray ionisation (API-ESI) interface (Bruker
Daltonic GmbH, Bremen, Germany). The mass spectrometer
was connected to an Agilent 1100 Series LC system, and was
operated in positive mode. The operating conditions of the
source were: 500 V end plate, þ4000 V capillary voltage,
2068.43 hPa nebuliser pressure, and 12 Lmin1 dry gas flow at a
dry temperature of 350 8C. The scan range was set to a mass to
charge value (m/z) varying between 50 and 1000, and the scan
time was 200ms.
For UV detection, a UV/Vis detector (Agilent G1314 A) was
used and absorbance maxima were measured at 210, 260, 275,
310 and 350 nm. Fluorescence was assessed with an Agilent
G1321 A fluorescence detector (excitation 278 nm, emission
445 nm).
Irradiation experiments and absorbance spectra
Irradiation experiments were performed using a TXE 150W
xenon lamp and a TQ 150 W medium-pressure mercury lamp
(UV-Consulting Peschl, Mainz, Germany) with stock solutions
of the test compounds in ultra-pure water as described else-
where.[16] The Hg lamp emits a low-intensity polychromatic
spectrum of radiation from 200 to 600 nm, with some higher
intensities at 254, 265, 302, 313, 366, 405/408, 436, 546 and
577/579 nm. According to the manufacturer, the total radiation
flux (F) from 200 to 600 nm amounts to 47 W and the maximal
intensities for whole spectral distribution were as follows: 4.0
(254), 1.4 (265), 1.8 (302), 4.3 (313), 6.4 (366), 3.2 (405/408),
4.2 (436), 5.1 (546) and 4.7W (577/579 nm). The Xe lamp has a
lower total photon flux and a continuous spectrum of radiation
from 300 to 800 nm.
The lamps were inserted into an immersion tube of silica
glass that was equipped with a cooling circuit to maintain the
temperature of the irradiated solutions at 20 2 8C. The stock
solutions of 10 mg L1 each were transferred into another
vessel, which surrounded the concentrically formed lamp and
the cooling circuit. These solutions were irradiated and further
evaluated in terms of DOC, HPLC-UV-MS experiments as
well as by the growth inhibition test. Furthermore, depending
on water solubility, concentrations of up to 1 g L1 were also
irradiated as a stock solution for the other toxicity assays.
Immediately following irradiation, the absorbance spectra
(Perking Elmer Instruments,Waltham,MA, USA) as well as the
DOC (see DOC measurement above) were measured.
Bacterial toxicity bioassays
Growth inhibition test (EN ISO 10712: 1995)
The growth inhibition test was performed according to the
EN ISO 10712 test guideline (1995) in order to investigate the
effects of the irradiated and non-irradiated samples on bacterial
growth (for details, see Bergheim et al.[16]). Briefly, a monocul-
ture strain of P. putida (ATCC 50026), obtained from the
German collection of microorganisms and cell cultures (DSMZ,
Braunschweig, Germany), was used as inoculum. The toxicity
of the test compounds was determined by comparing bacterial
growth in samples from the test vessels with those of the blanks
and without test compounds. This procedure was applied for the
irradiated and non-irradiated (parent compounds) solutions.
Bioluminescence assay
Application on TLC plate. For further assessment of bacte-
rial toxicity, 1mLup to amaximal 50 mL (100 ng up to amaximal
6mg) of the photodegradation samples (0 and 128 min) were
spotted band-wise (4 mm) on a thin-layer-chromatography
(TLC) plate (10 10 cm2) (Merck, Munich, Germany) with
fluorescent dye using a LINOMAT III (Camag, Mutenz,
Switzerland). For solvent and positive control, 2mL of distilled
water and 10mLof 3,5-dichlorophenol (concentration 50mgL1)
were spotted onto the TLC plate.
Photobacteria. To start the bacterial culture, freeze-dried
luminous bacteria (LUMISmini, LCK484, Hach Lange GmbH,
Du¨sseldorf, Germany) were pipetted into a reactivation solution
provided by the manufacturer. The bacteria were cultivated for
25 to 30 h in an autoclaved medium containing the following
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components: NaCl, NaH2PO4H2O, K2HPO4, MgSO4H2O,
(NH4)2HPO4, glycerine, peptone from casein and yeast extract.
To increase luminescence, 1.25 mL of phosphate buffer and
0.15mL of a 2.5% H2O2 solution were added to the bacterial
solution 15min before starting the test. After 15 min, the TLC
plate was dipped two times for 2 s into the bacteria suspension.
Redundant dipping solution was wiped off gently with a wiper.
After dipping the plate into the bacteria-containing solution, a
clean glass platewas placed on top of the TLCplate andwas then
directly placed below a light-sensitive camera (ST-1603ME
CCD camera with 1.56 megapixel, Santa Barbara Instrument
Group, Santa Barbara, CA, USA) at a distance of 30 cm
measuring the luminescence for 10min. A video–densitometric
quantification method was used to evaluate the degree of
inhibition of the bacterial illumination.[18]
Cell viability assays
To measure the PTP cytotoxicity to human cells, the water-
soluble tetrazolium (WST-1) assay and the neutral red (NR)-
uptake assaywere used. Both assayswere performed onHep-G2
cells (hepatocellular carcinoma), whereas the NR-uptake assay
was also performed on HeLa cells (human cervical cancer). The
cells were grown as a monolayer culture in T-75 flasks and sub-
cultured twice per week at 37 8C in a humid atmosphere con-
taining 5% CO2 in air. HeLa cells were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM, high glucose, Invitrogen,
Karlsruhe, Germany) supplemented with 10% foetal calf serum
(FCS) Gold (PAA, Pasching, Austria) and 1% penicillin–
streptomycin (PAA) supplemented with 15% FCS Gold 1%
penicillin–streptomycin. The adherent cells were detached by
adding 2–4mL of a mixture containing 0.25% trypsin þ 1mM
ethylenediaminetetraacetic acid (EDTA) (Invitrogen) and
5mgmL1 trypsin þ 2.2mgmL1 EDTA (Invitrogen).
WST-1 assay
For the WST-1 experiment, 5 105 Hep-G2 cells were
seeded in each well of a 96-well microplate and incubated for
24h. Subsequently, the medium was replaced with fresh medium
(200 mL per well) for the control sample, with medium contain-
ing the test solution (1 : 10) for the test wells, with medium and
distilled water (1 : 10) for the solvent controls and with medium
containing 0.01% Triton X (Merck, Darmstadt, Germany) for
the positive control. The microplate was incubated under
standard culture conditions for 48 h. Cells were then washed
with PBS (PAA) and a 5 vol % WST-1 solution (Roche Diag-
nostics, Mannheim, Germany) in a phenol red-free RPMI
medium (Invitrogen) was added to each well. After 1-h incuba-
tion at 37 8C, absorbance was measured at 435 nm using a
microplate reader (Tecan, Crailsheim, Germany).
NR-uptake assay
The NR-uptake assay was performed according to Repetto
et al.[19] Cells were seeded and treated as described above for the
WST-1 assay. HeLa cells and Hep-G2 were respectively seeded
into each well at a density of 4 103 and 5 105 cells per well.
After an exposure period of 48 h, cells were washed with PBS,
and 200 mL of fresh medium containing 0.5 mg L1 of NR
solution (stock solution was prepared with 4 mg L1 of NR;
Sigma–Aldrich, Taufkirchen, Germany) was added into each
well. After 3-h incubation at standard culture conditions, the
cells were again washed twice with 100 mL of PBS, and then
200mL of a destaining solution (ethanol 99%, formic acid 99%,
distilled water, v/v 50 : 1 : 49) were added. After shaking the
plate for 20min at 300 rpm, absorbance wasmeasured at 540 nm
using a microplate reader (Tecan, Crailsheim, Germany).
Genotoxicity: fluorimetric detection of alkaline DNA
unwinding (FADU)
Genotoxic effects of the PTPs were assessed by performing
the FADU assay.[20–22] Briefly, HeLa cells were cultivated and
treated as described for the cell viability assays. For the
experiments, 3 105 cells (for 1-h exposure) and 2 105 cells
(for 24-h exposure) were seeded into each well. Instead of a
chemical positive control, X-rays (X-ray generator: CHF
Mu¨ller, Hamburg, Germany, 70-keV energy) were used to
determine test reliability and cell sensitivity. For this purpose,
the X-ray dose was modified by variation of irradiation time at a
fixed dose rate. Cells were irradiated on ice in a 96-well plate
at the following condition: 3 min of irradiation with X-rays
corresponded to an energy dose of 1 Gy.
Cells were trypsined, washed with PBS and re-suspended in
suspension buffer (14mM b-mercaptoethanol, 250mM meso-
inositol, 1mMMgCl2, 10mM sodium phosphate buffer, pH 7.4)
at a final cell titre of 2 105 cells mL1. Aliqots (70mL) of the
cell suspensionwere pipetted into a 96-well plate. The next steps
were carried out by the automated FADU robot. First, 70 mL of
lysis buffer (9M urea, 10mMNaOH, 2.5mM 1,2-cyclohexane-
dinitrilotetraacetic acid, 0.1% SDS) was added and incubated
for 12 min at 0 8C. On top of the cell lysate, a pre-chilled
alkaline buffer (42% lysis buffer, 0.2M NaOH) was overlaid
and the alkaline unwinding was performed at 30 8C. After
60 min, 140 mL of a neutralisation buffer (81 M glucose,
14 mM b-mercaptoethanol) were added and incubated for
30 min at 22 8C. Samples were then mixed with Sybr-Green
solution (1 : 8333 (v/v) in H2O, Invitrogen). Fluorescence was
measured in a 96-well plate reader at 492 (excitation) and
520 nm (emission). All samples were measured as duplicates.
DNA integrity was calculated as described elsewhere.[23]
Results
Environmental concentrations and relevance
The calculated PECs (phase-I calculations) for all selected
compounds exceeded the action limit of 0.01 mgL1 (Table 3).
As recommended by the EMA, a more precise exposure calcu-
lation was therefore also conducted (phase-II calculations).
The results of phase-II calculations were one to three orders
of magnitude below the PECs of phase-I. The highest PEC
(phase-II) was calculated for allopurinol, but there are no data in
the literature on its occurrence in the aquatic environment. The
lowest PEC (phase-II) was calculated for the antifungal drug
fluconazole (Table 3). Most of the measured environmental
concentrations (MEC) taken from the literature were one or two
orders of magnitudes higher than the PEC (phase-II).
Biodegradability according to the OECD tests
All validity criteria of the OECD test guideline were met, and
none of the tested compounds were toxic to the inocula. Table 2
summarises the results of the three biodegradation tests.
Because biodegradability is related to the blank vessels and
expressed as a percentage, the result of the biodegradability
assessment can have negative values. For visual clarity these
were set to zero.
With respect to the oxygen consumption, all active com-
pounds could be classified as not readily biodegradable in
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the CBT and MRT. In the ZWT and in terms of DOC loss,
almost all compounds were further classified as not inherently
biodegradable. The only exceptions are the two active com-
pounds lisinopril and sotalol, for which DOC loss reached a
value of 69 and 71% at the end of the ZWT (Table 2).
Moreover, a DOC loss of at least 40% was reached for
primidone after 2 weeks, but no further DOC loss occurred to
the end of the test (Fig. 1).
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Fig. 1. Biodegradability shown exemplarily for primidone and monitored as oxygen consumption in the closed bottle test (CBT) and the manometric
respirometry test (MRT); also monitored as loss of dissolved organic carbon (DOC) in the Zahn–Wellens test (ZWT) over the Organisation of Economic
Cooperation and Development-standardised test period of 28 days.
Table 3. Predicted (PEC, phase-I and phase-II) and maximal measured environmental concentrations (max MEC)
PECs were calculated in accordance with the stepwise procedure of the two-phased European Medicines Evaluation Agency (EMA) guideline. Phase-I is an
exposure-driven screening phase, in which an approximate PEC is calculated by assuming that no biodegradation will occur. In phase-II, a refined PEC is
calculated. For comparison, MEC values taken from the literature are listed for various aquatic compartments. STP, sewage treatment plant; bd, below the
detection limit of the analysis technique
Test compound PEC phase-I (mg L1) PEC phase-II (ng L1) max MEC (ng L1) Aquatic compartment, country Ref.
aciclovir 20 263.6 600 STP effluents, China [40]
allopurinol 4 774.5 – – –
cetirizine 0.1 15.6 1200 surface waters, India [41]
11 surface waters, Sweden [42]
cimetidine 10 9.1 217 surface waters, Great Britain [43]
1338 surface waters, South Korea [44]
580 surface waters, USA [45]
fluconazole 2 5.0 111 surface waters, South Korea [46]
140 STP effluents, Sweden [47]
9 surface waters, Switzerland [48]
369 STP effluents, China [40]
hydrochlorothiazide 0.5 153.8 256 surface waters, Italy [49,50]
1949 STP effluents, Spain [24]
lisinopril 0.4 22.5 bd surface waters, Spain [24]
phenytoin 7.5 28.2 100 STP effluents, Germany [51]
19 drinking waters, USA [52,53]
primidone 7.5 54.8 690 ground waters, Germany [1]
89 surface waters, Germany [54]
51 drinking waters, Switzerland [55]
28 surface waters, USA [56]
ranitidine 4.5 301.6 39 surface waters, Italy [49,50,57]
70 surface waters, Great Britain [43]
100 surface waters, Sweden [58]
823 STP effluents, China [40]
10 surface waters, USA [45]
sotalol 2.4 27.2 1000 surface waters, Germany [2]
100 ground waters, Germany [2]
86 surface waters, Finland [25]
619 surface waters, Taiwan [26]
sulpiride 8 60.1 27 STP effluents, China [59]
100 STP influents, Japan [60]
tramadol 2 379.6 87 ground waters, Germany [54]
5970 surface waters, Great Britain [43]
1840 surface waters, Sweden [58]
valsartane 1.6 232.9 144 surface waters, Great Britain [43]
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Formation of phototransformation products (PTP)
With respect to the HPLC-UV-MS analysis, deviations of all
quality controls were within the limits of 20% for both
experiments (Xe and Hg lamp). Fig. 2 shows the variations in
DOC as well as the concentration of the test compounds as a
function of irradiation time for all active compounds and during
the irradiation experiments.
Over the course of the two irradiation experiments, the DOC
content remained constant for all compounds tested, irrespective
of the lamp used for the irradiation. Minor variations in DOC
content were only observed for valsartane.
Over the course of the irradiation experiment with the Hg
lamp, a constant and distinct decrease of concentration of the
parent compounds was recorded for all of the tested compounds,
except for aciclovir, allopurinol and fluconazole. In contrast,
over the entire irradiation with the Xe lamp, a distinct decrease
of the concentrations was only recorded for the three parent
compounds hydrochlorothiazide, ranitidine and tramadol, and
a minor decrease was additionally found for sotalol and valsar-
tane (Fig. 2).
Fig. S1 (Supplementary material) shows the absorbance
intensity of all non-irradiated and irradiated samples as a
function of wavelength and during the irradiation experiments
with the Hg lamp. The absorbance spectra of the solutions
containing the compounds cetirizine, hydrochlorothiazide, phe-
nytoin, ranitidine, sulpiride, tramadol and valsartane were
clearly modified during irradiation. No variations in the absor-
bance bands were found for the rest of the tested compounds’
solutions.
In contrast, when the irradiation experiments were carried
out with the Xe lamp, no variations of the absorbance bands
were found for any of the compounds. Only a minor decrease
of the absorbance maximum of hydrochlorothiazide was found
(data not presented).
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Fig. 2. Concentration of the parent compound (primary elimination, bars) and dissolved organic carbon (DOC) loss (lines) of all tested pharmaceutical
compounds over the course of 128-min irradiation with an Hg lamp (black) and a Xe lamp (grey). Results of ranitidine and tramadol are from Bergheim
et al.[16]
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The formation of PTPs was further investigated by means of
HPLC-UV-MS analysis. The intensity in the extracted ion
chromatogram (EIC) spectra in terms of signals and UV absor-
bencies were compared in each respective sample of the photo-
degradation experiments (data not presented). After irradiation,
newly formed MS signals or newly formed UV absorbencies
may both represent PTPs.
No such new signals were found in the HPLC-UV-MS
analysis for aciclovir, allopurinol or fluconazole. In combina-
tion with the corresponding constant DOC values mentioned
above, the constant concentration of the parent compounds as
well as the absorbance spectra, which remained invariable in
both quality and quantity, it becomes evident that no PTPs
were formed for these three active compounds, neither in the
experiments with the Hg lamp, nor in the experiments with the
Xe lamp.
However, for all other parent compounds, when exposed to
the Hg light source, new UV and MS signals as well as the
above-mentioned constant DOC values and the distinct reduc-
tion in concentration of the parent compounds make it apparent
that PTPs have been formed.
In contrast, when exposed to the Xe light source, new UV
and MS signals, reductions of the concentration of the parent
compounds as well as variations of the absorbance spectra are
much less significant, thus the extent of formation of PTPs is
less pronounced.
Toxicity against P. putida and V. fischeri
Toxicity was tested for all active compounds that were not
biodegradable and for all active compounds that were trans-
formed into PTPs during irradiation with the Hg lamp.
A first screen for bacterial toxicity was undertaken at a
relatively high concentration of 8mgL1 using the widespread
bacterial species P. putida. Comparing non-irradiated and
irradiated samples, toxicity was significantly higher in the
irradiated samples of cimetidine, tramadol and valsartane. An
increase of toxicity after irradiation was also found for the
antihistamine cetirizine (Fig. 3).
Further evaluation of bacterial toxicity was undertaken for
the same non-irradiated and irradiated active compounds using
V. fischeri luminescence bacteria. Results are shown in Fig. 4,
where inhibition of bioluminescence is plotted as a function of
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Fig. 3. Bacterial toxicity of all non-irradiated (black) and irradiated samples (light and dark grey) using the Hg lamp, relative to control (sterile-filtered
ultra-pure water) and monitored as growth inhibition of P. putida following 16-h exposure. Positive control (þ): 3,5-dichlorophenole (40mgL1). Each
bar represents themean s.e.m. of at least three independent experiments; *,P, 0.05; **,P, 0.01 v. non-irradiated sample (student’s t-test). Results of
ranitidine and tramadol for comparison (from Bergheim et al.[16]).
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concentration and irradiation exposure. Comparing non-
irradiated and irradiated samples, toxicity was significantly
higher for the irradiated samples of the pharmaceutical com-
pounds hydrochlorothiazide, ranitidine, sulpiride, tramadol and
valsartane. In contrast, after irradiation, toxicity was decreased
for phenytoin and cetirizine. No toxicity, neither for the non-
irradiated nor irradiated solutions, was found for primidone and
sotalol.
Cell viability and DNA integrity of Hep-G2 and HeLa cells
Toxicity was further investigated by means of two cell viability
tests (WST-1 and NR assays) and one genotoxicity test (FADU
assay) using human Hep-G2 and HeLa cells. Fig. 5 shows an
exemplary result for primidone.
The cell viability andDNA integrity ofHep-G2andHeLacells
were not affected by any of the pharmaceutical compounds tested.
Moreover, toxicity was not affected after exposure to the PTPs.
Discussion
In the present study the persistence of a series of selected
pharmaceuticals in the aquatic environment was evaluated with
respect to biotic and abiotic transformation processes and tox-
icity. These tests were performed in an effort to generate data to
prioritise the various substances for further testing.
Biodegradation
Biodegradation is the key degradation mechanism for organic
compounds in the aquatic environment. In this study, the bio-
degradability of 14 pharmaceutically active compounds was
investigated in detail with a test battery consisting of three
widely used and standardised OECD biodegradability tests. The
results demonstrate the high resistance of most of the investi-
gated compounds towards biological degradation processes.
Therefore, it can be assumed that without further treatment steps
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these substancesmay accumulate in aquatic systems. Our results
are consistent with the findings of other investigations, which
have documented the presence in different aquatic matrices of
most of the pharmaceuticals studied here (see Table 3). Sur-
prisingly, in the literature, the screening and detection of the
parent compound allopurinol in the aquatic environment has
not yet been described although our study revealed it to be
neither biodegradable nor photodegradable, and even though the
PEC value (775 ngL1, phase-II) estimated here for this com-
pound was actually the highest of all the PECs calculated.
Our investigations also show that under optimal conditions
the two active compounds sotalol and lisinopril are at least
inherently biodegradable. Similarly, Gros et al.[24] did not
detect lisinopril in surface waters. However, despite its strong
tendency to degrade biologically under optimal conditions,
sotalol has already been detected in different aquatic compart-
ments.[2,25,26] This pseudopersistence is obviously the result
of high discharge rates, and our study demonstrates that an
environmental risk assessment does not only have to take into
account biodegradation rates but also the detection of the parent
compounds of interest in the environment.
Phototransformation
The results of our irradiation experiments confirm that most
pharmaceuticals undergo phototransformation to form PTPs.
Only 3 (aciclovir, allopurinol and fluconazole) out of the 14
tested pharmaceutical compounds were completely resistant to
any UV- or light-induced transformation.
In order to study photodegradation we carried out two
different test series, in which PTPs were shown to be formed
by UV light (Hg lamp) or by simulated sunlight (Xe lamp),
although the latter produced only less PTPs even after 2 h of
direct irradiation because of the lower total energy emitted by
this lamp and the almost missing UV radiation of the spectrum
emitted. High-energy radiation is needed to degrade carbon–
carbon double and single bonds. Furthermore, the different
pharmaceuticals have different absorption maxima in terms of
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wavelength and absorbance intensity, i.e. differentmolar extinc-
tion coefficients. This explains the different results for the Hg
and the Xe lamps.
For standardisation we used ultra-pure water as recom-
mended by Fatta-Kassinos et al.[27] Although transformation
rates in natural water samples could be significantly higher –
because nitrate, nitrite and organic compounds such as humic
aids could act as photosensitiser in surface waters and accelerate
reaction rates[28,29] – radiationwill not penetrate thewholewater
body as underwater transmittance of sunlight is attenuated by
water itself and by dissolved and suspended organic matter,
which is present in natural water columns. Furthermore, the light
intensity depends on altitude and season. Therefore, we decided
to work with a highly standardised test system using purified
water only in order to obtain basic knowledge.
Our study demonstrates that the high-energy UV light (Hg
lamp) resulted in the formation of PTPs, even after a short period
of irradiation.As a consequence, routine use ofUV irradiation as
a new technology inwater purification is not appropriate, at least
not as a sole technique and without any further purification
steps. It can result in incomplete degradation of parent com-
pounds, and undesirable or possibly hazardous micropollutants
may be formed.
Nevertheless, photodegradation products of the compounds
studied here have not yet been identified in the aquatic environ-
ment and not yet been searched for, and it remains unclear
whether the PTPs determined during these laboratory-scale
experiments are also formed under natural conditions in the
aquatic environment. Consequently, not only must the issue of
reducing the emissions of parent compounds into the aquatic
environment be tackled, more work is also needed to character-
ise the chemical properties and toxicity of PTPs.
Toxicity
The possibility of multiple as well as long-term but unnoticed
toxicological effects on aquatic life or even on human beings
from exposure to PTPs is a matter of concern. We therefore not
only investigated the possible formation of PTPs, but also ini-
tiated first studies on the toxicity of the observed PTPs using
different in vitro screening test systems.
Two different bacterial strains were used for the bacterial
toxicity tests. The bacteria V. fischeri are commonly used in
monitoring studies as they have been shown to be very suitable
as a biological detector.[18] Nevertheless, V. fischeri is a marine
bacterium and not common in surface waters. Therefore we also
performed the growth inhibition test withP. putida, which is less
often used in monitoring studies, but is common in water and
soil habitats.
The results of our bacterial toxicity screening assays showed
irradiation to have a detoxifying effect on the two compounds
phenytoin and cetirizine albeit only in the bioluminescence
assay with V. fischeri. In contrast, a significant increase in
toxicity was recorded for most of the investigated parent
compounds after high-energetic UV irradiation (Hg lamp). For
example, the toxicity of irradiated samples of tramadol and
cimetidine (initial amount of each: 6mg per spot) were shown to
be significantly more toxic than the non-irradiated samples, and
even more toxic than the positive control 3,5-dichlorophenol
(0.1 mg per spot). Similarly, we found that the PTPs of sulpiride
were more toxic than the positive control 3,5-dichlorophenol
(0.1 mg per spot). To our knowledge there has been no previous
study dealing with the increased toxicity of sulpiride after
irradiation. Photochemical degradation was examined by
Skibin´ski et al.[9] for the structurally related compound amisul-
piride, but toxicity assessment for PTPs from amisulpiride has
not been reported. For ranitidine we also found that PTPs have
a higher toxicity towards V. fischeri than its parent compound,
whereby the effect was almost as high as the one of the positive
control (Fig. 4). This result is in accordance with studies carried
out by Isidori et al.,[14] who found that PTPs are more toxic to
crustaceans and rotifers than the parent compound ranitidine.
Isidori et al.[14] observed that ranitidine is oxidised at the sulfide
atom. Based on their results we conclude that the closely related
compound cimetidinemay also be oxidised at the sulfide atom,
because both compounds resemble each other in terms of their
thioether component. This hypothesis is further consolidated by
the result of our LC-MS analysis, where a new strong signal with
a corresponding [MþH]þ ion of m/z 269 was detected (Fig. S2
of the Supplementary material), which may represent the
oxidised cimetidine. Latch et al.[30] also suggested that cimeti-
dine sulfoxide represents a photolysis product.
Nevertheless, in Germany, an environmental risk from expo-
sure to PTPs of cimetidine is probably lowbecause of decreasing
prescription rates and the low PEC value (9 ng L1). However,
cimetidine is one of the four most abundantly used pharmaceu-
ticals in South Korea.[31] Consequently, environmental risks
cannot be fully excluded, especially because of the toxicity of
the irradiated parent compound cimetidine reported here.
We found the opposite results for cetirizine: toxicity was
reduced after irradiation in the V. fischeri bioluminescence
assay, but was increased in the P. putida growth inhibition test.
However, on its own the parent compound cetirizine was very
toxic to V. fischeri: at an initial amount of 6mg per spot it was
,2.5 times more toxic than the positive control. Interestingly,
all irradiated samples of the studied histamine H1- and H2-
antagonists (cimetidine, cetirizine and ranitidine) revealed
higher toxicity to at least one of the two bacterial strains used.
Whether the class of pharmacologic agents comprised by anti-
histamines is generally transformed into toxic PTPs should
be investigated in the future. Different outcomes of the two
bacterial toxicity tests were also found for the irradiated samples
of valsartane. Samples irradiated for 16min were more toxic
to V. fischeri than samples irradiated for 128 min, whereas
P. putidawas more susceptible to the 128-min sample. A strong
new signal with a corresponding [MþH]þ ion of m/z 414 was
detected in the LC-MS analysis for the 16-min sample but not for
the 128-min sample. Recently, Bianchini et al.[32] clarified the
chemical structure of two PTPs of valsartane with one PTP
showing the same signal with a corresponding m/z of 414
([MþH]þ). However, in the study presented here we could
clearly demonstrate for the first time that high-energy UV
irradiation of the parent compound valsartane generates toxic
PTPs.
With regard to the number of irradiated samples that have a
higher bacterial toxicity than the parent compound, the growth
inhibition test with P. putida seems to be less sensitive than the
V. fischeri bioluminescence assay. This finding is in accordance
with the fact that Pseudomonas species are common inhabitants
of aquatic environments[33] and thus are able to tolerate envi-
ronmental stresses.[34] Neumann et al.[35] showed that P. putida
are even able to change cell morphology as a response to toxic
compounds. An increase of the volume of the cell reduces the
overall membrane surface on which toxic compounds can
attach, and efflux pumps are more effective. Furthermore,
Vodovnik et al.[36] assumed that this adaptation is a consequence
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of changes in the fatty acid composition of the membrane. This
adaptation mechanism may be a reason why the two bacterial
toxicity tests exhibited different results for the compounds
hydrochlorothiazide, cetirizine, ranitidine, sulpiride and
valsartane. As a consequence, we recommend more detailed
ecotoxicity investigations for environmental risk assessment
studies on PTPs.
Once they have entered surface waters, recalcitrant PTPs
may also enter ground and drinking water. They can, however,
also be formed during UV disinfection of drinking water.
Expected concentrations of PTPs in drinking water are still
low and so far, studies to screen for cytotoxicity or genotoxicity
resulting from PTPs and tested with human cell lines are
extremely rare. To our knowledge there have been no compara-
ble previous studies on the evaluation of PTPs formed by
irradiation of pharmaceutical compounds. Thus, the aim of this
study was not only to assess the ecotoxicity of PTPs, but also to
conduct an initial screening of the cytotoxicity and genotoxicity
of the parent compounds and PTPs as a very first step in
assessing their possible risk to humans. We therefore also
screened for cytotoxicity in terms of lysosomal membrane
integrity and mitochondrial dehydrogenases activity, and for
genotoxicity with the FADU assay. To simulate realistic condi-
tions, we performed our experiments at the lowest concentra-
tions that could be tested (1 or 10 mg L1). During our study,
neither cytotoxicity nor genotoxicity were found for any of the
investigated pharmaceutical compounds and their respective
irradiated samples. However, in comparison with the results
from the bacterial toxicity tests it is important to keep in mind
that two completely different cells (bacteria and human cell
lines) were used.
In the literature it is often assumed that PTPs bear a higher
risk to humans and to aquatic life than the parent compounds.
This assumption is often made without any experimental evi-
dence.We recommend that literature dealingwith the toxicity of
PTPs should explicitly differentiate between the two notations
‘phototoxicity’ and ‘toxicity triggered by PTPs’. This becomes
obvious when looking at the OECD’s definition of phototoxi-
city, which states that phototoxicity is a toxic response from a
substance applied to the body, which is increased after the
body’s subsequent exposure to light.[37] Thus, this definition
does not describe phototoxicity as a toxic response resulting
from the uptake of PTPs. The need for a clear differentiation of
these terms is confirmed by the results from Han et al.,[38] who
proved phototoxic hemolysis for the PTPs of hydrochlorothia-
zide, albeit only if exposed cells were additionally irradiated.
Without further UV irradiation, the authors found that the PTPs
did not induce significant hemolysis. This low toxicity of the
PTPs from hydrochlorothiazide is in accordance with our results
from the toxicity assessment with human cell lines. Further-
more, we recommend also using the same clear notational
differentiation for the two terms ‘photogenotoxicity’ and ‘gen-
otoxicity of PTPs’. Chetelat et al.[39] proved that some fluor-
oquinolones induce photogenotoxic effects, whereas they did
not find any genotoxic effects when cells were exposedwith pre-
irradiated samples, hence, with samples containing the PTPs. In
the FADU assay conducted here, we also did not find any
genotoxic effects of the PTPs derived from the tested fluoro-
quinolones. We therefore strongly recommend that a clear
distinction should be made between ‘phototoxicity’ and ‘toxi-
city of PTPs’ to avoid false assumptions.
Furthermore, in view of the huge diversity of degradation
products in the aquatic environment it seems adequate to focus
first on the assessment of toxicity before extensive and costly
chemical analyses are conducted. We therefore recommend
toxicity screening before time-consuming structural elucidation
is initiated.
Summary
 None of the 14 active compounds tested could be classified as
readily biodegradable in the closed bottle and the manomet-
ric respirometry tests.
 Two (lisinopril and sotalol) out of fourteen investigated
active compounds could be classified as inherently biode-
gradable in the ZWT.
 The PECs according to phase-I of the EMA guideline
exceeded the action limit of 0.01mgL1.
 According to the literature all active compounds, except for
allopurinol and lisinopril, have been detected in aquatic
compartments.
 During 128-min irradiation with an Hg lamp, 11 (cetririzine,
cimetidine, hydrochlorothiazide, lisinopril, phenytoin,
primidone, ranitidine, sotalol, sulpiride, tramadol and
valsartane) out of 14 active compounds were transformed
into unknown PTPs.
 During 128-min irradiation with a Xe lamp, 3 (hydrochloro-
thiazide, ranitidine and tramadol) out of 14 active com-
pounds were partly transformed into unknown PTPs.
 Bacterial toxicity was found for the irradiated samples (Hg
lamp) of seven (cetirizine, cimetidine, hydrochlorothia-
zide, ranitidine, sulpiride, tramadol and valsartane) active
compounds in comparison to their respective non-irradiated
samples (i.e. parent compounds). For two irradiated samples
(cetirizine and phenytoin), bacterial toxicity to V. fischeri
was reduced after the irradiation process.
 None of the samples, non-irradiated or irradiated, were found
to be cytotoxic or genotoxic to human Hep-G2 and HeLa
cells.
Conclusions
 Many pharmaceutical compounds can be very resistant to
biological degradation and therefore, may accumulate in the
water cycle.
 The results show that PTPs are likely to be formed from
poorly biodegradable compounds during high-energy UV-
water treatment processes. Thus, in these cases water treat-
ment with UV light is not appropriate to completely degrade
or transform micropollutants into harmless compounds.
 The PTPs forming during this process can possibly pose a
higher risk to aquatic life because toxic effects to bacteria
have been proven in the present study. However, we have as
yet been unable to identify a risk to humans in the in vitro
toxicity tests with human cell lines.
 In view of the huge diversity of degradation products we
recommend to first focus on toxicity assessment before
extensive and costly analyses in terms of structural elucida-
tion are conducted.
Supplementary material
Additional material to this study (absorbance spectra, Fig. S1);
TIC, EIC and UV spectra, exemplarily shown for the photo-
degradation experiment with cimetidine, Fig. S2) is available
from the journal online (see http://www.publish.csiro.au/?
act=view_file&file_id=EN13218_AC.pdf).
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